Key takeaways
Without insurance coverage or discounts, the average out-of-pocket cost for Mounjaro (tirzepatide) is $1,529 per month.
Medicaid might cover Mounjaro when prescribed for Type 2 diabetes, but typically not for weight loss. Eli Lilly markets tirzepatide under the brand name Zepbound for weight management. In either case, coverage is up to each individual state.
The cost of Mounjaro after Medicaid coverage depends on the state’s cost-sharing requirements—including copays, deductibles, and coinsurance—and whether Mounjaro is one of their “preferred” drugs.
Mounjaro (tirzepatide) is an injectable medication prescribed for Type 2 diabetes, but some healthcare providers prescribe it off-label for weight loss. At first glance, Mounjaro might look pretty pricey, but its out-of-pocket costs can vary drastically based on insurance coverage, discounts, pharmacy location, and more. In limited instances, Medicaid programs may cover Mounjaro for weight loss, but it depends on the state, and most only cover it for diabetes treatment. Here’s all the important information about Mounjaro’s Medicaid coverage.
How much does Mounjaro cost?
The list price for brand-name products can be steep, and Mounjaro is no exception. Without help from a health insurance plan, Medicare Part D, or Medicaid, Mounjaro costs an average of $1,526 for 4, 5 mL pens.
Save up to 80% on Mounjaro with SingleCare Different pharmacies offer different prices for the same medication. SingleCare helps find the best price for you.
Does Medicaid cover Mounjaro?
Medicaid is a federal- and state-funded program that provides free or steeply discounted health insurance, often including coverage for prescription drugs. Over 70 million Americans received Medicaid assistance in 2025, including prescription drug coverage for Mounjaro.
Does Medicaid cover Mounjaro for diabetes?
Medicaid sometimes covers Mounjaro for Type 2 diabetes treatment. In 2022, the year Mounjaro hit the market, Medicaid dispersed nearly $30 million to help beneficiaries pay for it, according to KFF data.
Yet that’s not necessarily a guarantee. Medicaid might cover it in some circumstances but not others. For example, Sarah Bonza, MD, founder of Bonza Health, says, “I just had a 49-year-old patient with a new diagnosis of diabetes and atrial fibrillation. I tried to prescribe Mounjaro, which helps with heart failure and diabetes, but I couldn’t get it covered.”
Diabetes Coupons & Discount Diabetic Supplies
Does Medicaid cover Mounjaro for weight loss?
That said, some people might receive assistance, but usually only if it’s prescribed for diabetes, not weight management. Legislation passed in 2003 prohibits Medicare from covering drugs prescribed specifically for weight loss, and while Medicaid has more flexibility here, not every state will cover them. Mounjaro’s only on-label use is for diabetes, so Medicaid likely won’t cover it for weight loss. However, some states may cover it in extremely limited situations, and many are considering expanding coverage.
Eli Lilly markets tirzepatide under the brand name Zepbound as a weight-loss medication. Alex Foxman, MD, physician and medical director for Achieve Health and Weight Loss, says, “They are exactly the same medication with exactly the same dosing schedule.” KFF data indicates that Medicaid spent around $39 million in 2022 covering Wegovy, a similar drug that’s approved specifically for obesity treatment. Regardless, Medicaid beneficiaries should check with their state to see whether their plan might cover Mounjaro or Zepbound.
RELATED: Zepbound vs. Mounjaro
Costs of Mounjaro under Medicaid
All 50 states include some prescription drug coverage in their Medicaid plans. The question is how much coverage. Each state gets to dictate its own insurance premiums and out-of-pocket requirements, including deductibles, copays, and coinsurance. This is called cost sharing.
Medicaid allows states to decide which medicines on their drug lists are “preferred” or “non-preferred,” and states can use these out-of-pocket requirements to push patients toward their preferred—typically less expensive—medications. People with incomes above 150% of the federal poverty level could pay up to 20% of the drug’s cost in copays, while people at or below 150% will only pay nominal amounts.
Mounjaro will likely be cheaper in states that consider it a preferred drug than in states where it’s nonpreferred. Check with your state’s Department of Health to inquire about Medicaid cost-sharing requirements.
Factors influencing Medicaid coverage of Mounjaro
The purpose of the prescription, or the “indication,” is the main factor determining whether Medicaid will cover Mounjaro. Some people received coverage for Type 2 diabetes, but not many for weight loss.
And even if a state covers Mounjaro, some may have prior authorization requirements. According to Dr. Bonza, these requirements might include a documented diagnosis of Type 2 diabetes mellitus and confirmation with a medical test. She also says some patients must get prior authorization every year. In certain cases, the state may request that a patient try certain preferred medications before it approves Mounjaro, a process known as step therapy. This can happen if it classifies Mounjaro as a nonpreferred option.
Right now, it appears as though most Medicaid programs might prefer more established medications. “I am seeing Ozempic (semaglutide) approval at a higher rate than Mounjaro, even though the cost of Ozempic is higher,” Dr. Foxman says. “I believe that as pharmacy benefit managers (PBMs) and insurance companies better understand the power of these medications and the likely long-term overall patient cost reduction due to better outcomes, these medications will be better covered.”
It’s important to remember that these are relatively new drugs, and the landscape is constantly changing. Continue checking with your insurance provider to verify whether coverage has changed.
Ways to get discounts on Mounjaro
Using Medicaid or other insurance coverage is one of the best ways to reduce the cost of Mounjaro, but for people who don’t have insurance or whose plans might not prefer it, there are other ways to save. For example, SingleCare discounts can knock over $650 off the cash price of Mounjaro—and it’s free to sign up. Members can use SingleCare if they’re on Medicaid, but they can’t stack the discounts on top of Medicaid coverage.
RELATED: How does SingleCare work?
Be wary of any sources that claim to be selling generic or steeply discounted Mounjaro. The Food and Drug Administration has discovered counterfeit Ozempic pens and is investigating counterfeit Mounjaro sales as well. When looking for ways to save on Mounjaro, be sure to get it from a licensed, reputable healthcare provider.
The SingleCare prices in this article are the most accurate at the time of publishing in ZIP code 23666 as of Dec. 9, 2025. Prices vary by pharmacy. Visit our Mounjaro coupon page for updated Mounjaro prices near you.
- June 2025 Medicaid & CHIP enrollment data highlights, Centers for Medicare & Medicaid Services (2025)
- Medicaid utilization and spending on new drugs used for weight loss, KFF (2023)
- H.R.1 – Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Congress.gov
- Medicaid utilization and spending on new drugs used for weight loss, KFF (2023)
- Beneficiary resources, Centers for Medicare & Medicaid Services
- Cost sharing, Centers for Medicare & Medicaid Services
- Current and resolved drug shortages and discontinuations reported to FDA, U.S. Food and Drug Administration
- FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain, Food and Drug Administration (2023)